Perspective · 30 Mar 2022
Short communicationPublished 2018
Treatment for Psoriasis using Retinoids
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Treatment of moderate-to-serious plaque psoriasis regularly requires the utilization of phototherapy or fundamental treatment, which incorporates immunosuppressants, retinoids, and biologic specialists. Albeit biologic use is getting progressively well known, it isn't extraordinary for patients to encounter treatment disappointment. We portray a patient who had an imperfect reaction to etanercept monotherapy following twelve weeks of enlistment dosing (50 mg twice week after week), just as to a mix of etanercept (50 mg once week by week upkeep dosing) and narrowband bright B (NB-UVB) phototherapy multiple times week by week for an extra twelve weeks. Perceptible improvement was noted after the expansion of NB-UVB and the patient's promising reaction to phototherapy impacted further administration. Etanercept and NB-UVB were ceased and the patient was started on excimer laser medicines twice week after week. Following a month, the patient had a 75 percent decrease in Psoriasis Area Severity Index (PASI) score and following 7 weeks had more than 95 percent leeway of psoriasis. The special properties of the excimer laser may represent its clinical viability in our patient just as in different instances of obstinate psoriasis. We suggest that the excimer laser be considered in instances of biologic or regular phototherapy disappointment notwithstanding being a standard treatment choice or subordinate for the treatment of psoriasis.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference proceeding · Dec 2020
A Review of the Efficacy and Safety of Retinoids in the Treatment of Ultraviolet Related Skin Conditions and Skin Ageing
Conference abstract · 21 Jun 2020
Assessment of the efficacy and tolerance of a new combination of retinoids and de-pigmenting agents in the treatment of melisma- Maria Vitale- Madrid, Spain
Conference abstract · 22 Jun 2015
Assessment of the efficacy and tolerance of a new combination of retinoids and de-pigmenting agents in the treatment of melasma
Conference abstract · 22 Jun 2015
Assessment of the efficacy and tolerance of a new combination of retinoids and depigmenting agents in the treatment of melasma
More from this journal
The newest in Archives of Industrial Biotechnology.
Commentary · 28 Feb 2025
Industrial Biotechnology in Wastewater Treatment and Pollution Control
Brief report · 28 Feb 2025
Advances in Enzyme Engineering for Industrial Biotechnology.
Editorial · 28 Feb 2025
CRISPR and Genome Editing in Industrial Microorganisms.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalArchives of Industrial Biotechnology
- SubjectBiochemistry & Biotechnology
- SubjectEngineering
- BylineArticles whose byline prints “Javier Dooenck”

